Cargando…

Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a relapsing chronic disorder of the gastrointestinal tract characterized by disruption of epithelial barrier function and excessive immune response to gut microbiota. The lack of biomarkers providing early diagnosis or defining the status of the pathology difficul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauset, Cristina, Gisbert-Ferrándiz, Laura, Cosín-Roger, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915257/ https://www.ncbi.nlm.nih.gov/pubmed/33562024 http://dx.doi.org/10.3390/jcm10040622

Ejemplares similares

IFNγ-Treated Macrophages Induce EMT through the WNT Pathway: Relevance in Crohn’s Disease
por: Macias-Ceja, Dulce C., et al.
Publicado: (2022)

Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development
por: Ortiz-Masiá, Dolores, et al.
Publicado: (2020)

Is the Macrophage Phenotype Determinant for Fibrosis Development?
por: Lis-López, Lluis, et al.
Publicado: (2021)

SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis
por: Bauset, Cristina, et al.
Publicado: (2022)

Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review
por: Aldars-García, Laila, et al.
Publicado: (2021)

Autophagy Stimulation as a Potential Strategy Against Intestinal Fibrosis
por: Cosin-Roger, Jesus, et al.
Publicado: (2019)

Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis
por: Baldan-Martin, Montse, et al.
Publicado: (2023)

Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease
por: Zheng, Xiaowen, et al.
Publicado: (2017)

Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
por: Alsoud, Dahham, et al.
Publicado: (2022)

Microbiome, Metabolome and Inflammatory Bowel Disease
por: Ahmed, Ishfaq, et al.
Publicado: (2016)

Urine metabolome profiling of immune-mediated inflammatory diseases
por: Alonso, Arnald, et al.
Publicado: (2016)

Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease
por: Shao, Jing, et al.
Publicado: (2021)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
por: Duvoisin, Gilles, et al.
Publicado: (2017)

Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?
por: Cosín-Roger, Jesús, et al.
Publicado: (2020)

Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
por: Aldars-García, Laila, et al.
Publicado: (2021)

Biomarkers of Metabolomics in Inflammatory Bowel Disease and Damp-Heat Syndrome: A Preliminary Study
por: Wu, Xingxing, et al.
Publicado: (2022)

Diminished Vitamin D Receptor Protein Levels in Crohn’s Disease Fibroblasts: Effects of Vitamin D
por: Gisbert-Ferrándiz, Laura, et al.
Publicado: (2020)

Serum galectins as potential biomarkers of inflammatory bowel diseases
por: Yu, Tony B., et al.
Publicado: (2020)

Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel Disease
por: Jaenisch, Simone E., et al.
Publicado: (2022)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

The Involvement of Intestinal Tryptophan Metabolism in Inflammatory Bowel Disease Identified by a Meta-Analysis of the Transcriptome and a Systematic Review of the Metabolome
por: Wang, Shan, et al.
Publicado: (2023)

2523 Noninvasive biomarkers for inflammatory bowel disease: Drawbacks and potential
por: Patel, Vihang, et al.
Publicado: (2018)

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease
por: Guo, Xue, et al.
Publicado: (2022)

Urinary chemerin as a potential biomarker for inflammatory bowel disease
por: Gunawan, Stefan, et al.
Publicado: (2022)

Biomarkers of Inflammatory Bowel Disease
por: Fengming, Yi, et al.
Publicado: (2014)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

Telemedicine: A promising future for inflammatory bowel disease management
por: Fazal, Faizan, et al.
Publicado: (2022)

Suitability of Dried Blood Spots for Accelerating Veterinary Biobank Collections and Identifying Metabolomics Biomarkers With Minimal Resources
por: Allaway, David, et al.
Publicado: (2022)

Potential Biomarkers of Fatigue Identified by Plasma Metabolome Analysis in Rats
por: Kume, Satoshi, et al.
Publicado: (2015)

Potential osteomyelitis biomarkers identified by plasma metabolome analysis in mice
por: Isogai, Norihiro, et al.
Publicado: (2020)

Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine
por: Di Minno, Alessandro, et al.
Publicado: (2022)

Translational Potential of Metabolomics on Animal Models of Inflammatory Bowel Disease—A Systematic Critical Review
por: Knudsen, Lina Almind, et al.
Publicado: (2020)

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
por: Xu, Xinwei, et al.
Publicado: (2022)

Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy
por: Xu, Jia, et al.
Publicado: (2022)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease
por: Jiang, Huali, et al.
Publicado: (2021)

Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics
por: Voskuil, Michiel Dirk, et al.
Publicado: (2019)

Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress
por: van Wassenaer, Elsa A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1fmfs9jm9aoej54jo6gpivrbjq